Journal
ARCHIVES OF TOXICOLOGY
Volume 91, Issue 5, Pages 2235-2244Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s00204-016-1877-6
Keywords
NF-kappa B/IL-6/STAT3 axis; Metabolomics; Alpha-naphthyl isothiocyanate; Drug toxicity
Categories
Funding
- National Key Research and Development Program [2016YFC0903100, 2016YFC0903102]
- Intramural Research Program of the Center for Cancer Research
- National Cancer Institute
- National Institutes of Health
- Tianjin Project of Thousand Youth Talents, Tianjin
- Tianjin application foundation and advanced technology research plan [15JCYBJC54700]
- China Postdoctoral Science Foundation [2016M590210]
- Tianjin Health Bureau Science Foundation Key Project [2014KR14]
- project for Individualized diagnosis and treatment of colorectal cancer [LNCCC-B05-2015]
Ask authors/readers for more resources
Alpha-naphthyl isothiocyanate (ANIT)-induced liver damage is regarded as a useful model to study druginduced cholestatic hepatitis. Ultra-performance liquid chromatography coupled with electrospray ionization quadrupole mass spectrometry (UPLC-ESI-QTOF MS)based metabolomics revealed clues to the mechanism of ANIT-induced liver injury, which facilitates the elucidation of drug-induced liver toxicity. 1-Stearoyl-2-hydroxysn- glycero-3-phosphocholine (LPC 18: 0) and 1-oleoyl-2- hydroxy-sn-glycero-3-phosphocholine (LPC 18: 1) were significantly increased in serum from ANIT-treated mice, and this increase resulted from altered expression of genes encoding the lipid metabolism enzymes Chka and Scd1. ANIT also increased NF-kappa B/IL-6/STAT3 signaling, and in vitro luciferase reporter gene assays revealed that LPC 18: 0 and LPC 18: 1 can activate NF-kappa B in a concentrationdependent manner. Activation of PPARa through feeding mice a Wy-14,643-containing diet (0.1%) reduced ANIT-induced liver injury, as indicated by lowered ALT and AST levels, and liver histology. In conclusion, the present study demonstrated a role for the lipid-regulated NF-kappa B/IL-6/STAT3 axis in ANIT-induced hepatotoxicity, and that PPARa may be a potential therapeutic target for the prevention of drug-induced cholestatic liver injury.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available